Diginex Limited (NASDAQ:DGNX - Get Free Report) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling 474,272 shares, a growth of 31.5% from the December 15th total of 360,550 shares. Approximately 0.3% of the company's shares are short sold. Based on an average daily volume of 467,308 shares, the short-interest ratio is presently 1.0 days. Based on an average daily volume of 467,308 shares, the short-interest ratio is presently 1.0 days. Approximately 0.3% of the company's shares are short sold.
Institutional Trading of Diginex
Large investors have recently bought and sold shares of the company. Armistice Capital LLC purchased a new stake in Diginex during the third quarter worth approximately $144,000. PharVision Advisers LLC acquired a new stake in Diginex in the third quarter valued at approximately $262,000. UBS Group AG lifted its position in shares of Diginex by 562.8% during the third quarter. UBS Group AG now owns 46,141 shares of the company's stock worth $664,000 after purchasing an additional 39,179 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Diginex by 10.0% in the second quarter. Geode Capital Management LLC now owns 19,315 shares of the company's stock valued at $994,000 after purchasing an additional 1,748 shares during the period. Finally, Tudor Investment Corp ET AL purchased a new position in Diginex in the 3rd quarter valued at about $168,000.
Diginex Stock Down 2.3%
DGNX stock traded down $0.05 on Friday, hitting $2.12. The company's stock had a trading volume of 2,197,885 shares, compared to its average volume of 1,440,143. Diginex has a 1 year low of $0.45 and a 1 year high of $39.85. The firm has a 50 day moving average of $8.24 and a two-hundred day moving average of $10.67.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Diginex in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Diginex presently has an average rating of "Sell".
Read Our Latest Report on Diginex
About Diginex
(
Get Free Report)
Diginex Limited NASDAQ: DGNX is a digital asset financial services and solutions provider catering to institutional clients and professional investors. The company offers end-to-end trading, custody, banking and advisory services across a range of digital assets. Through its proprietary platform, Diginex delivers secure and compliant market access, enabling clients to trade, hold and transact cryptocurrencies and tokenized assets with institutional-grade infrastructures.
Key offerings include the EQUOS digital asset exchange, which provides spot and derivatives trading, as well as a suite of custody and settlement solutions designed to meet stringent regulatory requirements.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diginex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diginex wasn't on the list.
While Diginex currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.